Manganese neurotoxicity is a hallmark of Hypermanganesemia with Dystonia 2, an inherited manganese transporter defect caused by mutations in SLC39A14. To identify novel potential targets of manganese neurotoxicity we performed transcriptome analysis of slc39a14−/- mutant zebrafish unexposed and exposed to MnCl2. Differentially expressed genes mapped to the central nervous system and eye, and pathway analysis suggested that calcium dyshomeostasis and activation of the unfolded protein response are key features of manganese neurotoxicity. Consistent with this interpretation, MnCl2 exposure led to decreased whole animal calcium levels, locomotor defects and changes in neuronal activity within the telencephalon and optic tectum. In accordance with reduced tectal activity, slc39a14−/- zebrafish showed changes in visual phototransduction gene expression, absence of visual background adaptation and a diminished optokinetic reflex. Finally, numerous differentially expressed genes in mutant larvae normalised upon MnCl2 treatment indicating that, in addition to neurotoxicity, manganese deficiency is present either subcellularly or in specific cells or tissues. Overall, we assembled a comprehensive set of genes that mediate manganese-systemic responses and found a highly correlated and modulated network associated with calcium dyshomeostasis and cellular stress.
Loss of slc39a14 causes simultaneous manganese hypersensitivity and deficiency in zebrafish
- Award Group:
- Funder(s): Medical Research Council
- Award Id(s): MR/V006754/1
- Funder(s):
- Award Group:
- Funder(s): Action Medical Research
- Award Id(s): GN1999
- Funder(s):
- Award Group:
- Funder(s): Wellcome Trust
- Award Id(s): 104682/Z/14/Z
- Funder(s):
- Award Group:
- Funder(s): Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung
- Award Id(s): 31003A_173083
- Funder(s):
- Award Group:
- Funder(s): Biotechnology and Biological Sciences Research Council
- Award Id(s): BB/T001844/1
- Funder(s):
- Award Group:
- Funder(s): Comisin Nacional de Investigacin Cient-fica y Tecnologica
- Award Id(s): REDI170300
- Funder(s):
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Accepted Manuscript 06 May 2022
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Karin Tuschl, Richard J. White, Chintan Trivedi, Leonardo E. Valdivia, Stephanie Niklaus, Isaac H. Bianco, Chris Dadswell, Ramón González-Méndez, Ian M. Sealy, Stephan C. F. Neuhauss, Corinne Houart, Jason Rihel, Stephen W. Wilson, Elisabeth M. Busch-Nentwich; Loss of slc39a14 causes simultaneous manganese hypersensitivity and deficiency in zebrafish. Dis Model Mech 2022; dmm.044594. doi: https://doi.org/10.1242/dmm.044594
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. Submission deadline: 4 July 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists